KEQUNasdaqLaboratory Apparatus & FurnitureFiscal year ends April 30
KEWAUNEE SCIENTIFIC CORP /DE/
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026
$32.10−0.82 (-2.51%)
Close on Oct 19, 2026
- Market cap
- $93.76M
- P/E (TTM)
- 11.6
- Dividend yield
- –
Kewaunee Scientific statistics
Financials through Jul 31, 2026, price as of Oct 19, 2026, median of Laboratory Apparatus & Furniture companies for comparison
Valuation
| Measure | Kewaunee Scientific | Industry median |
|---|---|---|
| Market Cap | $92.94M | $230.55M |
| Enterprise Value | $105.74M | $202.97M |
| PE Ratio | 11.63 | 33.40 |
| PS Ratio | 0.34 | 3.11 |
| PB Ratio | 1.24 | 3.14 |
| P/TBV Ratio | 1.99 | 4.57 |
| P/FCF Ratio | 8.54 | 27.25 |
| P/OCF Ratio | 6.27 | 22.35 |
Enterprise value
| Measure | Kewaunee Scientific | Industry median |
|---|---|---|
| EV / Sales | 0.38 | 2.92 |
| EV / EBITDA | 4.94 | 19.86 |
| EV / EBIT | 7.02 | 24.88 |
| EV / FCF | 9.72 | 27.85 |
Income (trailing twelve months)
| Measure | Kewaunee Scientific | Industry median |
|---|---|---|
| Revenue | $277.22M | $102.39M |
| Gross Profit | $79.15M | $60.36M |
| Operating Income | $15.06M | -$4.31M |
| Pretax Income | $12.37M | -$2.26M |
| Net Income | $8.23M | -$6.57M |
| EBITDA | $21.39M | -$1.98M |
| EPS (Diluted) | $2.76 | -$0.07 |
Margins
| Measure | Kewaunee Scientific | Industry median |
|---|---|---|
| Gross Margin | 28.6% | 55.1% |
| Operating Margin | 5.43% | -6.04% |
| Pretax Margin | 4.46% | -4.11% |
| Profit Margin | 2.97% | -10.5% |
| EBITDA Margin | 7.71% | -2.67% |
| FCF Margin | 3.92% | -0.30% |
Returns
| Measure | Kewaunee Scientific | Industry median |
|---|---|---|
| Return on Equity (ROE) | 11.6% | -19.2% |
| Return on Assets (ROA) | 4.46% | -13.3% |
| Return on Invested Capital (ROIC) | 13.1% | -4.11% |
| Return on Capital Employed (ROCE) | 11.7% | -9.07% |
Growth
| Measure | Kewaunee Scientific | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 5.33% | 8.85% |
| Net Income Growth (YoY) | -33.1% | 10.6% |
| EPS Growth (YoY) | -33.2% | 10.6% |
| FCF Growth (YoY) | -41.8% | 10.6% |
| Revenue Growth (3Y CAGR) | 8.71% | 7.08% |
| Revenue Growth (5Y CAGR) | 13.8% | 11.8% |
| EPS Growth (3Y CAGR) | 134.4% | 3.06% |
Balance sheet
| Measure | Kewaunee Scientific | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $8.25M | $37.33M |
| Total Debt | $18.83M | $72.66M |
| Net Cash (Debt) | -$10.59M | $3.92M |
| Net Cash Per Share | -$3.66 | $0.28 |
| Equity (Book Value) | $75.01M | $57.36M |
| Book Value Per Share | $25.91 | $2.81 |
| Tangible Book Value | $46.61M | $10.71M |
| Working Capital | $56.72M | $54.64M |
Financial position
| Measure | Kewaunee Scientific | Industry median |
|---|---|---|
| Current Ratio | 2.20 | 2.50 |
| Quick Ratio | 1.41 | 1.54 |
| Debt / Equity | 0.25 | 0.38 |
| Debt / EBITDA | 0.88 | 2.31 |
| Debt / FCF | 1.73 | 3.50 |
| Net Debt / EBITDA | 0.50 | 1.53 |
| Interest Coverage | 4.39 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Kewaunee Scientific | Industry median |
|---|---|---|
| Operating Cash Flow | $14.82M | -$653.46K |
| Capital Expenditures | -$3.94M | -$3.69M |
| Free Cash Flow | $10.88M | -$835.02K |
| FCF Per Share | $3.76 | -$0.02 |
Efficiency
| Measure | Kewaunee Scientific | Industry median |
|---|---|---|
| Asset Turnover | 1.50 | 0.59 |
| Inventory Turnover | 6.12 | 2.21 |
Dividends and yields
| Measure | Kewaunee Scientific | Industry median |
|---|---|---|
| Earnings Yield | 8.86% | -6.91% |
| FCF Yield | 11.7% | -0.56% |
Shares
| Measure | Kewaunee Scientific | Industry median |
|---|---|---|
| Shares Outstanding | 2,895,350 | 44,856,700 |
| Shares Change (YoY) | -0.18% | 3.35% |
| Shares Change (QoQ) | 1.01% | 0.27% |
| Float | 2,428,160 | 37,097,900 |
| Shares Held by Insiders | 16.1% | 10.6% |
| Shares Held by Institutions | 41.4% | 63.5% |
Taxes
| Measure | Kewaunee Scientific | Industry median |
|---|---|---|
| Income Tax | $3.22M | $1.52M |
| Effective Tax Rate | 26.1% | 18.6% |
Scores
| Measure | Kewaunee Scientific | Industry median |
|---|---|---|
| Graham Number | $40.11 | $34.37 |
| Graham Upside | 24.9% | -57.7% |
| Altman Z-Score | 3.37 | 1.95 |
| Piotroski F-Score | 4 | 5 |
Calculated by StockData from Kewaunee Scientific's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.